EXTENDICARE INC (EXE.CA) Fundamental Analysis & Valuation

TSX:EXE • CA30224T8639

Current stock price

26.35 CAD
-0.07 (-0.26%)
Last:

This EXE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. EXE.CA Profitability Analysis

1.1 Basic Checks

  • In the past year EXE was profitable.
  • EXE had a positive operating cash flow in the past year.
  • EXE had positive earnings in each of the past 5 years.
  • In the past 5 years EXE always reported a positive cash flow from operatings.
EXE.CA Yearly Net Income VS EBIT VS OCF VS FCFEXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of EXE (10.41%) is better than 84.62% of its industry peers.
  • EXE's Return On Equity of 55.53% is amongst the best of the industry. EXE outperforms 92.31% of its industry peers.
  • EXE has a better Return On Invested Capital (18.54%) than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EXE is above the industry average of 7.68%.
  • The 3 year average ROIC (11.40%) for EXE is below the current ROIC(18.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.41%
ROE 55.53%
ROIC 18.54%
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
EXE.CA Yearly ROA, ROE, ROICEXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • The Profit Margin of EXE (5.72%) is better than 84.62% of its industry peers.
  • EXE's Profit Margin has improved in the last couple of years.
  • EXE's Operating Margin of 8.22% is fine compared to the rest of the industry. EXE outperforms 76.92% of its industry peers.
  • EXE's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 14.15%, EXE is doing worse than 76.92% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EXE has grown nicely.
Industry RankSector Rank
OM 8.22%
PM (TTM) 5.72%
GM 14.15%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
EXE.CA Yearly Profit, Operating, Gross MarginsEXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EXE.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXE is creating value.
  • The number of shares outstanding for EXE has been increased compared to 1 year ago.
  • Compared to 5 years ago, EXE has less shares outstanding
  • Compared to 1 year ago, EXE has an improved debt to assets ratio.
EXE.CA Yearly Shares OutstandingEXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EXE.CA Yearly Total Debt VS Total AssetsEXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • EXE has an Altman-Z score of 3.83. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
  • EXE's Altman-Z score of 3.83 is amongst the best of the industry. EXE outperforms 84.62% of its industry peers.
  • The Debt to FCF ratio of EXE is 3.39, which is a good value as it means it would take EXE, 3.39 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.39, EXE is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
  • A Debt/Equity ratio of 1.94 is on the high side and indicates that EXE has dependencies on debt financing.
  • EXE has a worse Debt to Equity ratio (1.94) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF 3.39
Altman-Z 3.83
ROIC/WACC2.49
WACC7.44%
EXE.CA Yearly LT Debt VS Equity VS FCFEXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • EXE has a Current Ratio of 0.81. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.81, EXE perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.81, EXE is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
EXE.CA Yearly Current Assets VS Current LiabilitesEXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. EXE.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 52.52% over the past year.
  • EXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.74% yearly.
  • Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 11.59% in the last year.
  • The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%

3.2 Future

  • Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.99% on average per year.
  • The Revenue is expected to grow by 15.18% on average over the next years. This is quite good.
EPS Next Y31.96%
EPS Next 2Y19.6%
EPS Next 3Y18.96%
EPS Next 5Y16.99%
Revenue Next Year15.35%
Revenue Next 2Y24.05%
Revenue Next 3Y18.09%
Revenue Next 5Y15.18%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXE.CA Yearly Revenue VS EstimatesEXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
EXE.CA Yearly EPS VS EstimatesEXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. EXE.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • EXE is valuated quite expensively with a Price/Earnings ratio of 25.34.
  • EXE's Price/Earnings ratio is a bit cheaper when compared to the industry. EXE is cheaper than 76.92% of the companies in the same industry.
  • EXE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.70.
  • A Price/Forward Earnings ratio of 23.09 indicates a rather expensive valuation of EXE.
  • Based on the Price/Forward Earnings ratio, EXE is valued a bit cheaper than 76.92% of the companies in the same industry.
  • EXE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 25.34
Fwd PE 23.09
EXE.CA Price Earnings VS Forward Price EarningsEXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 76.92% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
  • EXE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EXE is cheaper than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.97
EV/EBITDA 16.08
EXE.CA Per share dataEXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of EXE may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXE's earnings are expected to grow with 18.96% in the coming years.
PEG (NY)0.79
PEG (5Y)1.11
EPS Next 2Y19.6%
EPS Next 3Y18.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. EXE.CA Dividend Analysis

5.1 Amount

  • EXE has a Yearly Dividend Yield of 1.91%.
  • Compared to an average industry Dividend Yield of 1.38, EXE pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, EXE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

  • The dividend of EXE has a limited annual growth rate of 2.79%.
  • EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
EXE.CA Yearly Dividends per shareEXE.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • EXE pays out 45.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.22%
EPS Next 2Y19.6%
EPS Next 3Y18.96%
EXE.CA Yearly Income VS Free CF VS DividendEXE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
EXE.CA Dividend Payout.EXE.CA Dividend Payout, showing the Payout Ratio.EXE.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXE.CA Fundamentals: All Metrics, Ratios and Statistics

EXTENDICARE INC

TSX:EXE (3/13/2026, 7:00:00 PM)

26.35

-0.07 (-0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners23.28%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap2.49B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts78
Price Target24.43 (-7.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date02-27
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.07%
PT rev (3m)3.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.28%
EPS NY rev (3m)-1.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 25.34
Fwd PE 23.09
P/S 1.57
P/FCF 24.97
P/OCF 16.29
P/B 15.19
P/tB N/A
EV/EBITDA 16.08
EPS(TTM)1.04
EY3.95%
EPS(NY)1.14
Fwd EY4.33%
FCF(TTM)1.06
FCFY4.01%
OCF(TTM)1.62
OCFY6.14%
SpS16.83
BVpS1.74
TBVpS-0.37
PEG (NY)0.79
PEG (5Y)1.11
Graham Number6.37
Profitability
Industry RankSector Rank
ROA 10.41%
ROE 55.53%
ROCE 24.53%
ROIC 18.54%
ROICexc 26.92%
ROICexgc 58.63%
OM 8.22%
PM (TTM) 5.72%
GM 14.15%
FCFM 6.27%
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF 3.39
Debt/EBITDA 1.91
Cap/Depr 150.97%
Cap/Sales 3.34%
Interest Coverage 9.89
Cash Conversion 92.12%
Profit Quality 109.55%
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 3.83
F-Score6
WACC7.44%
ROIC/WACC2.49
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y31.96%
EPS Next 2Y19.6%
EPS Next 3Y18.96%
EPS Next 5Y16.99%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year15.35%
Revenue Next 2Y24.05%
Revenue Next 3Y18.09%
Revenue Next 5Y15.18%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.63%
EBIT Next 3Y17.9%
EBIT Next 5Y14.02%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%

EXTENDICARE INC / EXE.CA Fundamental Analysis FAQ

What is the fundamental rating for EXE stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.


What is the valuation status for EXE stock?

ChartMill assigns a valuation rating of 5 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.


What is the profitability of EXE stock?

EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for EXE stock?

The Earnings per Share (EPS) of EXTENDICARE INC (EXE.CA) is expected to grow by 31.96% in the next year.


Is the dividend of EXTENDICARE INC sustainable?

The dividend rating of EXTENDICARE INC (EXE.CA) is 5 / 10 and the dividend payout ratio is 45.22%.